Therapy for severe psoriasis
| LEADER | cam a22 4500 | ||
|---|---|---|---|
| 001 | 528952552 | ||
| 003 | CHVBK | ||
| 005 | 20200927092732.0 | ||
| 006 | m d | ||
| 007 | cr |n |||||||| | ||
| 008 | 170510s2017 pauac sb 001 0 eng d | ||
| 010 | |a 2017288327 | ||
| 016 | 7 | |a 101700824 |2 DNLM | |
| 020 | |a 978-0-323-44797-3 | ||
| 020 | |a 0-323-44797-X | ||
| 035 | |a (SERSOL)ssj0001791940 | ||
| 035 | |a (WaSeSS)ssj0001791940 | ||
| 040 | |a NLM |b eng |c NLM |d BTCTA |d BDX |d WSU |d YDXCP |d OCLCF |d DLC |d WaSeSS |e rda | ||
| 050 | 0 | 0 | |a RL321 |b .T5 2017 |
| 060 | 0 | 0 | |a 2017 B-305 |
| 060 | 1 | 0 | |a WR 205 |
| 082 | 0 | 0 | |a 616.5/2606 |2 23 |
| 245 | 0 | 0 | |a Therapy for severe psoriasis |c [edited by] Jashin J. Wu, MD, Los Angeles, CA, USA, Steven R. Feldman, MD, PhD, Departments of Dermatology, Pathology, and Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA, Mark G. Lebwohl, MD, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA |
| 264 | 1 | |a Philadelphia |b Elsevier |c [2017] | |
| 300 | |a 1 online resource (xiii, 195 pages) |b illustrations, portraits | ||
| 336 | |a text |b txt |2 rdacontent/eng | ||
| 337 | |a computer |b c |2 rdamedia/eng | ||
| 338 | |a online resource |b cr |2 rdacarrier/eng | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a 1. Overview of psoriasis / Michael Kelly-Sell and Johann E. Gudjonsson -- 2. Ultraviolet B phototherapy / Sandra Pena, Dane Hill, and Steven J. Feldman -- 3. Psoralen-ultraviolet light A therapy / Lauren M. Madigan and Henry W. Lim -- 4. Methotrexate / Vidhi V. Shah, Elaine J. Lin, Shivani P. Reddy, and Jashin J. Wu -- 5. Acitretin / Elaine J. Lin, Vidhi V. Shah, Shivani P. Reddy, and Jashin J. Wu -- 6. Cyclosporine / Vidhi V. Shah, Shivani P. Reddy, Elaine J. Lin, and Jashin J. Wu -- 7. Apremilast / Amit Om, Dane Hill, and Steven R. Feldman -- 8. Etanercept / Shivani P. Reddy, Vidhi V. Shah, Elaine J. Lin, and Jashin J. Wu -- 9. Infliximab / Catherine Ni, Shivani P. Reddy, and Jashin J. Wu -- 10. Adalimnumab / Shivani P. Reddy, Elaine J. Lin, Vidhi V. Shah, and Jashin J. Wu -- 11. Ustekinumab / John K. Nia and Mark G. Lebwohl -- 12. Secukinumab / Elaine J. Lin, Shivani P. Reddy, Vidhi V. Shah and Jashin J. Wu -- 13. Ixekizumab / Shivani P. Reddy, Vidhi V. Shah and Jashin J. Wu -- 14. Biosimilars / Shivani P. Reddy, Catherine Ni, and Jashin J. Wu -- 15. Combination therapies for psoriasis / Anjali S. Vekaria and Mark G. Lebwohl -- 16. Investigational therapies for psoriasis / Peter W. Hashim and Mark G. Lebwohl. | |
| 506 | |a Lizenzbedingungen können den Zugang einschränken. License restrictions may limit access. | ||
| 650 | 0 | |a Psoriasis |x Treatment | |
| 650 | 1 | 2 | |a Psoriasis |x therapy |
| 650 | 7 | |a Psoriasis |x Treatment |0 (OCoLC)fst01080967 |2 fast | |
| 700 | 1 | |a Wu |D Jashin J. |e editor | |
| 700 | 1 | |a Feldman |D Steven R. |e editor | |
| 700 | 1 | |a Lebwohl |D Mark |e editor | |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/book/9780323447973 |z Uni Bern: Volltext |
| 898 | |a BK020053 |b XK020053 |c XK020000 | ||
| 909 | 4 | |f ScienceDirect eBooks | |
| 909 | 4 | |a E-Books von 360MarcUpdates | |
| 949 | |B IDSBB |F B405 |b B405 |c 405VT |x NELB4051809 | ||
| 950 | |B IDSBB |P 700 |E 1- |a Wu |D Jashin J. |e editor | ||
| 950 | |B IDSBB |P 700 |E 1- |a Feldman |D Steven R. |e editor | ||
| 950 | |B IDSBB |P 700 |E 1- |a Lebwohl |D Mark |e editor | ||
| 950 | |B IDSBB |P 856 |E 40 |u https://www.sciencedirect.com/science/book/9780323447973 |z Uni Bern: Volltext | ||